Lise Lecointre is an expert in Gynecology at Hôpitaux Universitaires de Strasbourg (France). Lise Lecointre has authored 194 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 7 of them ongoing. SLR score: 606 (community average: 125). How the SLR is computed.

LeadR Profile

606 ScienceLeadR Reputation 606
Network Map

Gynecology

Subspecialties: Oncology - Obstetrics - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Hôpital d'Hautepierre

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Special situations in cervical cancer management: de novo metastatic disease, occult cancer after simple hysterectomy, and cervical stump cancer - A review from the french cervical cancer guidelines group.
PMID 42946053 — radiotherapy, hysterectomy, uterine cervical neoplasms, brachytherapy, neoplasms, immunotherapy, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
PMID 42946055 — radiotherapy, conization, uterine cervical neoplasms, brachytherapy, neoplasms, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
FERTILITY-SPARING SURGERY AND OVARIAN TRANSPOSITION IN CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
PMID 42946052 — radiotherapy, fertility, trachelectomy, safety, conization, hysterectomy, uterine cervical neoplasms, ovary, neoplasms, lymph, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
Vaginal Sclerotherapy for Endometrioma: A Retrospective Study on Feasibility and Impact on Fertility.
PMID 42686058 — endometriosis, pregnancy, fertility, minimally invasive surgical procedures, ovary, retrospective studies, sclerotherapy, cysts, gynecology, history
J Gynecol Obstet Hum Reprod20260
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
PMID 42673357 — ultrasonography, obstetrics, ultrasonography, prenatal, gynecology
Ultrasound Obstet Gynecol20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 6
Phase 3 2

By status:

Recruiting 6
Not yet recruiting 1
Unknown 1

By type:

Interventional 4
Observational 4

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 2
multicentricup10 0

Main Topics

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff
NCT07336017 — encopresis, diagnosis, delivery rooms, morbidity, education, wounds and injuries, postpartum period
N/ARecruiting2025
COVARIAN Contribution of contrast enhanced ultrasound for diagnosis of adnexal torsion
2024-511720-13-00 — diagnosis
Phase 3Recruiting2025
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 — ovary, neoplasms, ovarian neoplasms, therapeutics, carcinoma, ovarian epithelial, carcinoma
N/ARecruiting2024
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53 Mutated Endometrial Cancer A Non Inferiority Randomized Trial
NCT06900582 — genes, lymph nodes, lymph node excision, ureter, neoplasms, sentinel lymph node, biopsy, arteries, genes, p53, lymph, tissues, ligaments, sentinel lymph node biopsy, indocyanine green, anatomy, iliac artery, mutation, dissection, endometrial neoplasms, cervix uteri
N/ANot yet recruiting2026
Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion
NCT06677554 — injections, contrast media, ovarian torsion, emergencies, ovary, diagnosis, therapeutics, women
Phase 3Recruiting2025

LeadR Networks

Main global connection map